OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding novel COVID-19: Its impact on organ failure and risk assessment for diabetic and cancer patients
Begum Dariya, Ganji Purnachandra Nagaraju
Cytokine & Growth Factor Reviews (2020) Vol. 53, pp. 43-52
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)
Balamurugan Shanmugaraj, Konlavat Siriwattananon, Kittikhun Wangkanont, et al.
Asian Pacific Journal of Allergy and Immunology (2020)
Open Access | Times Cited: 482

The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase
Jrhau Lung, Yu‐Shih Lin, Yao‐Hsu Yang, et al.
Journal of Medical Virology (2020) Vol. 92, Iss. 6, pp. 693-697
Open Access | Times Cited: 289

Vitamin D Status in Hospitalized Patients with SARS-CoV-2 Infection
José L. Hernández, Daniel Nan, Marta Fernández‐Ayala, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 106, Iss. 3, pp. e1343-e1353
Open Access | Times Cited: 269

S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates
Joshua G. Liang, Danmei Su, Tian‐Zhang Song, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 155

Fear of COVID‐19 Scale (FCV‐19S) across countries: Measurement invariance issues
Chung‐Ying Lin, Wen‐Li Hou, Mohammed A. Mamun, et al.
Nursing Open (2021) Vol. 8, Iss. 4, pp. 1892-1908
Open Access | Times Cited: 151

Global COVID-19 Vaccine Acceptance: A Systematic Review of Associated Social and Behavioral Factors
Choudhary Sobhan Shakeel, Amenah Abdul Mujeeb, Muhammad Shaheer Mirza, et al.
Vaccines (2022) Vol. 10, Iss. 1, pp. 110-110
Open Access | Times Cited: 141

Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?
Simone Cristina Soares Brandão, Júlia de Oliveira Xavier Ramos, Luca Terracini Dompieri, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 58, pp. 102-110
Open Access | Times Cited: 89

Distribution of the environmental and socioeconomic risk factors on COVID-19 death rate across continental USA: a spatial nonlinear analysis
Yaowen Luo, Jianguo Yan, Stephen C. McClure
Environmental Science and Pollution Research (2020) Vol. 28, Iss. 6, pp. 6587-6599
Open Access | Times Cited: 81

Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19)
Monic Andrew, G. Jayaraman
Carbohydrate Research (2021) Vol. 505, pp. 108326-108326
Open Access | Times Cited: 67

In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2
Satyajit Beura, Prabhakar Chetti
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 10, pp. 3747-3759
Open Access | Times Cited: 68

<p>Knowledge, Attitude, Practice, and Associated Factors Regarding the Novel Coronavirus Disease 2019 (COVID-19) Pandemic</p>
Addisu Dabi Wake
Infection and Drug Resistance (2020) Vol. Volume 13, pp. 3817-3832
Open Access | Times Cited: 65

Repurposing benzimidazole and benzothiazole derivatives as potential inhibitors of SARS-CoV-2: DFT, QSAR, molecular docking, molecular dynamics simulation, and in-silico pharmacokinetic and toxicity studies
Ranjan K. Mohapatra, Kuldeep Dhama, Amr Ahmed El‐Arabey, et al.
Journal of King Saud University - Science (2021) Vol. 33, Iss. 8, pp. 101637-101637
Open Access | Times Cited: 51

In silico studies on phytochemicals to combat the emerging COVID-19 infection
Mohnad Abdalla, Ranjan K. Mohapatra, Ashish K. Sarangi, et al.
Journal of Saudi Chemical Society (2021) Vol. 25, Iss. 12, pp. 101367-101367
Open Access | Times Cited: 50

Comparing Fear of COVID-19 and Preventive COVID-19 Infection Behaviors Between Iranian and Taiwanese Older People: Early Reaction May Be a Key
Amir H. Pakpour, Chieh-hsiu Liu, Wen‐Li Hou, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 47

The Coronavirus pandemic – 2022: Viruses, variants & vaccines
Magdalini Alexandridi, Julija Mazej, Enrico Palermo, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 63, pp. 1-9
Open Access | Times Cited: 35

Dendrimer as a momentous tool in tissue engineering and regenerative medicine
Aazam Shaikh, Prashant Kesharwani, Virendra Gajbhiye
Journal of Controlled Release (2022) Vol. 346, pp. 328-354
Closed Access | Times Cited: 33

Dynamical demeanour of SARS-CoV-2 virus undergoing immune response mechanism in COVID-19 pandemic
Jayanta Mondal, Piu Samui, Amar Nath Chatterjee
The European Physical Journal Special Topics (2022) Vol. 231, Iss. 18-20, pp. 3357-3370
Open Access | Times Cited: 32

Liver injury in COVID-19: Clinical features, potential mechanisms, risk factors and clinical treatments
Shuwu Zhao, Yiming Li, Yilin Li, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 2, pp. 241-256
Open Access | Times Cited: 17

Raloxifene as a treatment option for viral infections
Subin Hong, JuOae Chang, Kwiwan Jeong, et al.
The Journal of Microbiology (2021) Vol. 59, Iss. 2, pp. 124-131
Open Access | Times Cited: 38

Therapeutic use of Guggulsterone in COVID-19 induced obesity (COVIBESITY) and significant role in immunomodulatory effect
L. Preethi, Nila Ganamurali, Dhivya Dhanasekaran, et al.
Obesity Medicine (2021) Vol. 24, pp. 100346-100346
Open Access | Times Cited: 34

Page 1 - Next Page

Scroll to top